sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Europe Narcolepsy Market Scope And Analysis

  • Report Code : TIPRE00008098
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 123
Buy Now

Europe Narcolepsy Market Analysis, Scope, and Growth by 2027

Buy Now

Europe Narcolepsy Market Report Europe Narcolepsy Market Size and Share Europe Narcolepsy Market Scope and Analysis

Europe Narcolepsy Market Report Scope

Report Attribute Details
Market size in 2018 US$ 671.1 Million
Market Size by 2027 US$ 1,532.5 Million
Global CAGR (2019 - 2027) 9.7%
Historical Data 2016-2017
Forecast period 2019-2027
Segments Covered By Type
  • Narcolepsy with Cataplexy
  • Narcolepsy without Cataplexy
  • Secondary Narcolepsy
By Product
  • Central Nervous System Stimulants
  • Sodium Oxybate
  • Antidepressants
By Distribution Channel
  • Hospital Pharmacies and Retail Pharmacies
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • Teva Pharmaceutical Industries Ltd
  • Jazz Pharmaceuticals plc
  • Arena Pharmaceuticals Inc
  • Graymark Healthcare Inc
  • Novartis AG
  • Takeda Pharmaceutical Company Limited
  • Mylan N V
  • BIOPROJET
  • Shionogi Co Ltd